| ||||||||||||||
|
|
|||||||||||||

Department of *Anesthesiology, Weill-Cornell Medical Center, New York, New York; and
Cardiothoracic Intensive Care Unit, New York Methodist Hospital, Brooklyn, New York
Address correspondence and reprint requests to Adam Lichtman, MD, 356 Clinton Street #2, Brooklyn NY 11231. Address e-mail to divemd{at}att.net.
Malignant hyperthermia (MH) is a rare hypermetabolic disorder of skeletal muscle that can be fatal if not recognized and treated aggressively. We describe a patient with a suspected family history of MH who developed hyperpyrexia, acidosis, and hypermetabolism after cardiac surgery despite a nontriggering anesthetic. No drugs were identified as being causative and we theorize that systemic rewarming was the inciting cause of MH in this MH-susceptible individual via a mechanism similar to heat stroke.
This article has been cited by other articles:
![]() |
A. D. Lichtman and C. Oribabor If It Quacks Like a Duck Then ...! Anesth. Analg., June 1, 2007; 104(6): 1612 - 1613. [Full Text] [PDF] |
||||
![]() |
T. Girard and A. Urwyler Not Every Hypermetabolic State Is Due to Malignant Hyperthermia! Anesth. Analg., June 1, 2007; 104(6): 1611 - 1612. [Full Text] [PDF] |
||||
![]() |
S. M. Siddik-Sayyid, A. R. Moussa, and A. S. Baraka Can We Prevent Malignant Hyperthermia After Hypothermic Cardiopulmonary Bypass in a Malignant Hyperthermia-Susceptible Patient? Anesth. Analg., January 1, 2007; 104(1): 214 - 214. [Full Text] [PDF] |
||||
![]() |
A. D. Lichtman and C. Oribabor Can We Prevent Malignant Hyperthermia After Hypothermic Cardiopulmonary Bypass in a Malignant Hyperthermia-Susceptible Patient? Anesth. Analg., January 1, 2007; 104(1): 214 - 215. [Full Text] [PDF] |
||||
|